Edwards Lifesciences Corp (NYSE:EW) currently has a daily average trading volume of 4.05M but it saw 2203092 shares traded in last market. With a market cap of 50.80B USD, the company’s current market price of $84.30 came falling about -0.44 while comparing to the previous closing price of $84.67. In past 52 weeks, the stock remained buoying in the range of price level as high as $96.12 and as low as $60.57.
Taking a look at 20-day trading activity of Edwards Lifesciences Corp (EW) gives us an average price of $88.70, while its current price level is -12.30% below from 52-week high level whereas it is 39.18% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $90.00 while that of 200 days or SMA-200 reads an average of $78.53. A closer look into the stock’s movement over the week reveals that its volatility is standing at 2.85% during that period while stretching the period over a month that decreases to 2.35%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 33.40 which implies that the stock is in neutral territory.
Wells Fargo upgraded its recommendation for the stock as a “Overweight” from “Equal Weight” on February 02, 2024 while assigning a price target of $94. Evercore ISI issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $80 and $77.
Over the week, EW’s stock price is moving -4.86% down while it is -10.61% when we observe its performance for the past one month. Year-to-date it is 10.56% up and over the past year, the stock is showing a downside performance of -3.71%.
Currently, Edwards Lifesciences Corp’s total number of outstanding shares is 601.10M. Company’s return on investment (ROI) stands at 18.14% and return on equity (ROE) at 21.59%. It has a price to earnings ratio (P/E ratio) of 36.23 while having a 27.08 of forward P/E ratio. Stock’s beta reads 1.10. Stock has a price to book (P/B) ratio of 7.13 while price to sale or P/S ratio amounts to 8.27. Its return on asset (ROA) is 15.38% on average.
